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The insertion of peripheral intravenous catheters (PIVCs) is common for treatment among hospitalized patients. However, 
this procedure usually fails before the end of therapy because of several complications, including phlebitis. Therefore, 
this study aimed to determine the incidence and associated factors of phlebitis among patients with PIVC. A prospective 
cohort study was conducted in one of the hospitals located in East Coast Malaysia. The presence of phlebitis was assessed 
using the visual infusion phlebitis score checklist. The patients were followed until PIVC removal. A total of 321 data 
were collected among patients who received a new PIVC in the medical, gynecology, and orthopedic wards. The incidence 
of phlebitis was 36.1% (n= 116), and 96.6% of which were grade II. Patients aged 60 years (51.5%), men (42.2%), no 
known phlebitis history (47.4%), and with chronic disease record (46.8%) were determined as the highest percentage with 
phlebitis. This study demonstrated that age, gender, and chronic diseases were risk factors of developing phlebitis. 
 




Karakteristik Pasien yang Berhubungan dengan Flebitis di Rumah Sakit Pantai Timur Semenanjung Malayía. Di 
antara pasien yang dirawat di rumah sakit, penyisipan kateter intravena perifer (PIVC) umum untuk pengobatan. Namun, 
prosedur ini seringkali gagal sebelum terapi selesai karena beberapa komplikasi. Salah satu komplikasi yang terjadi 
adalah flebitis. Oleh karena itu, penelitian ini bertujuan untuk menentukan kejadian dan faktor-faktor terkait flebitis di 
antara pasien dengan PIVC. Sebuah studi kohort prospektif dilakukan di salah satu rumah sakit yang berlokasi di Pantai 
Timur Malaysia. Kejadian flebitis dinilai menggunakan daftar periksa skor Visual Infusion Phlebitis (VIP). Para pasien 
ditindaklanjuti sampai pengangkatan PIVC. Terdapat 321 data yang dikumpulkan di antara pasien yang menerima PIVC 
baru di bangsal medis, ginekologi, dan ortopedi. Insiden flebitis ditemukan 36,1% (n= 116), 96,6% di antaranya adalah 
grade II. Pasien berusia 60 tahun (51,5%), pria (42,2%), pasien tidak memiliki riwayat flebitis (47,4%) dan pasien 
dengan catatan penyakit kronis (46,8%) tercatat sebagai persentase tertinggi dengan flebitis. Studi ini menunjukkan 
bahwa usia, jenis kelamin, dan pasien dengan penyakit kronis kemungkinan besar mengalami flebitis. 
 






The indispensable usage of peripheral intrave-
nous catheters (PIVCs) plays a significant aid 
in administering non-oral fluids, nutrition, and 
medications. It poses an essential risk to the 
health and safety of millions of hospitalized pa-
tients (Ho & Cheung, 2012; Tee et al., 2015). 
However, up to 75% of hospitalized patients 
developed phlebitis, which is a common PIVC 
complication (Enes et al., 2016). Phlebitis is an 
issue that influences patients with PIVC and 
impacts hospital cost and treatment process, 
which may lead to further complications such 
as catheter-related infection (Wallis et al., 2014). 
This issue is also notable among low-middle 
countries. Nobre and da Silva Martins (2018) 
defined phlebitis as inflammation of the vein 
wall and can be accompanied by symptoms such 
as pain, edema, and erythema near the catheter 
insertion site or along the affected vein, some-
times progressing to a palpable venous cord, in- 
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tense redness, tenderness, and fever. 
 
In Malaysia, there is a lack of study regarding 
phlebitis and its risk factors, and only a few stu-
dies regarding thrombophlebitis or an advanced 
stage of phlebitis and its risk factor were con-
ducted. Tan et al. (2012) reported a 32.5% inci-
dence of thrombophlebitis among patients with 
PIVC in tertiary hospitals in Malaysia. The sig-
nificant risk factors that contributed to the high 
incidence were dwelling time, infusate type, 
and gender. In Indonesia, the incidence rate of 
phlebitis was 40%, and a relationship between 
nurses’ knowledge about infusion therapy and 
phlebitis percentage was found (Wayunah et al., 
2013). A study in South Korea identified four 
significant predictive factors (six categories) of 
PIVC-related phlebitis for orthopedic patients, 
namely, vein quality, contrast agent use, hand 
hygiene, and nursing experience (Lee et al., 
2019). 
 
More evidence is needed to explore and identi-
fy the significant risk factors that contribute to 
phlebitis among patients with PIVC. Therefore, 
this study aimed to determine phlebitis inciden-
ce and the contributing factors among patients 
with PIVCs. One of the main objectives of the 
Ministry of Health (MOH) of Malaysia is to 
reduce the incidence of PIVC-related infection. 
The study findings will support the revision of 
the guidelines of PIVC management by the 
MOH to minimize the risk of phlebitis and sub-
sequently reduce infections on the ward, pro-
vide safer hospital environments, and reduce 
costs to hospitals in infection control manage-
ment (Choong et al., 2010). Phlebitis leads to 
increased discomfort in patients, more extended 
hospital stay, and higher healthcare costs (Wallis 
et al, 2014), and these risks can be minimized 




A prospective cohort study was conducted in 
one of the hospitals in East Coast Malaysia. The 
data were collected for 5 months. Approval from 
the Institutional Research Committee Board was 
obtained before data collection. A consecutive 
sampling method was used to recruit 321 res-
pondents, and the participants were among pa-
tients who had PIVC in the medical, gyneco-
logy, and orthopedic wards. The inclusion crite-
ria for this study were patients who received a 
new PIVC upon assessment, voluntarily agreed 
to participate in the study, and signed the writ-
ten informed consent, which consists of the stu-
dy details and participants’ rights. The study 
excluded patients who were critical, on IV che-
motherapy drugs, and with current infection. 
 
The PIVC assessment of eligible participants 
was performed daily, starting from the first day 
of PIVC insertion to the day of PIVC removal. 
The assessment continued for 3 days post-PIVC 
removal. A data collection sheet was used to col-
lect data on patient-related and outcome (phle-
bitis) characteristics. The incidence of phlebitis 
was evaluated using a modified visual infusion 
phlebitis (VIP) score checklist adapted from the 
Royal College of Nursing (2010). The VIP sco-
re checklist measures the presence, location, 
and severity of phlebitis. A score of 0 implies 
no signs of phlebitis; 1, possible first signs of 
phlebitis; 2, early stage of phlebitis; 3, medium 
stage of phlebitis; 4, advanced stage of phle-
bitis/start of thrombophlebitis; 5, advanced sta-
ge of thrombophlebitis. The phlebitis score was 
recorded for each PIVC. 
 
SPSS software version 25.0 was used for data 
entry and analysis. Descriptive statistics were 
used to analyze the data. The associated factors 





The mean age of the patients in this study was 
47 (±17.9) years, with most of the patients aged 
60 years and above (30.2%). Most participants 
were women (52.0%), from the medical ward 
(55.5%), and have no phlebitis history (50.5%). 
In this study, 43.3% of patients were diagnosed 
with chronic diseases, such as diabetes mellitus, 
hypertension, chronic kidney disease, and heart 
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disease. Table 1 shows detailed information on 
patient characteristics. 
 
Of patients with PIVCs, 36.1% (116/321) expe-
rienced phlebitis. The reason for PIVC removal 
was discharged, dislodged, treatment completi-
on, leakage, and patient request. Most phlebitis 
patients had a VIP score of two (96.6%), and 
the rest had three (3.4%). The details of the re-
sults are shown in Table 2. 
 
The incidence of phlebitis, according to patient 
characteristics, is exhibited in Table 3. Patients 
aged 60 years and above recorded the highest 
 
 
Table 1. Patient Characteristics (n= 321) 
 
Characteristics 
Patients with PIVC 
N (%) Mean (SD) 
Age (years) 321 (100)  
Age (categorical), years  47 (±17.9) 
18–29 72 (22.4)  
30–39 63 (19.6)  
40–49 32 (10.0)  
50–59 57 (17.8)  
≥60 97 (30.2)  
Gender   
Male 154 (48.0)  
Female 167 (52.0)  
History of phlebitis   
Yes 64 (19)  
No 162 (50.5)  
Unknown 95 (29.6)  
Type of admission   
Medical 178 (55.5)  
Orthopedic 54 (16.8)  
Gynecology 89 (27.7)  
Presence of chronic disease   
Yes 139 (43.3)  
No 182 (56.7)  
 
*PIVC, peripheral intravenous catheter; SD, standard deviation. 
 
 
Table 2. The Incidence Rate of Phlebitis, Reasons of PIVC Removal, and Score of Phlebitis (n= 321) 
 
Variables Frequency (n) Percentage (%) 
Phlebitis   
Yes 116 36.1 
No 205 63.9 
Reasons of PIVC removal   
Phlebitis 116 36.1 
Discharged 121 37.7 
Dislodged 44 13.7 
Treatment completion 3 9.0 
Leakage 19 5.9 
Patient request 5 1.5 
Not removed/not changed 13 4.0 
Phlebitis score (n =116)   
2 112 96.6 
3 4 3.4 
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N (%) N (%) 
Age (categorical), years     
18–29 13 18.1 59 81.9 
30–39 19 30.2 44 69.8 
40–49 12 37.5 20 62.5 
50–59 22 38.6 35 61.4 
≥60 50 51.5 47 48.5 
Gender     
Male 65 42.2 89 57.8 
Female 51 30.5 116 69.5 
History of phlebitis     
Yes 29 45.3 35 54.7 
No 42 25.9 120 74.1 
Unknown 45 47.4 50 52.6 
Type of admission     
Medical 69 38.8 109 61.2 
Orthopedic 21 38.9 33 61.1 
Gynecology 26 29.2 63 70.8 
Presence of chronic disease     
Yes 65 46.8 74 53.2 
No 51 28.0 131 72.0 
 
 






N (%) N (%)  
Age (categorical), years     < 0.001* 
18–29 13 18.1 59 81.9  
30–39 19 30.2 44 69.8  
40–49 12 37.5 20 62.5  
50–59 22 38.6 35 61.4  
≥60 50 51.5 47 48.5  
Gender     0.03* 
Male 65 42.2 89 57.8  
Female 51 30.5 116 69.5  
History of phlebitis     < 0.001* 
Yes 29 45.3 35 54.7  
No 42 25.9 120 74.1  
Unknown 45 47.4 50 52.6  
Type of admission     0.28* 
Medical 69 38.8 109 61.2  
Orthopedic 21 38.9 33 61.1  
Gynecology 26 29.2 63 70.8  
Presence of chronic disease     < 0.001* 
Yes 65 46.8 74 53.2  
No 51 28.0 131 72.0  
 
*Pearson Chi-square test, p< 0.05 is significant at 95% confidence interval 
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phlebitis percentage (51.5%) and the largest po-
pulation with PIVCs in this study. Besides, of 
116 phlebitis patients, 42.2% were men and had 
a higher incidence rate of phlebitis than women, 
and 47.4% of patients had no known history of 
phlebitis but developed the condition later on. 
Most of the patients with phlebitis were admit-
ted to the orthopedic ward (38.9%). Meanwhile, 
patients with a chronic disease record had the 
highest incidence of phlebitis (46.8%). 
 
Table 4 shows the associated factors of phle-
bitis related to patient characteristics. The fin-
dings determined that patients’ age (χ²= 21.33; 
p< 0.001), gender (χ²= 4.73; p= 0.03), history 
of phlebitis (χ²= 14.85; p< 0.001), and pre-
sence of chronic diseases (χ²= 11.99; p< 0.001) 
gave a significant association in the develop-




This current study underlined a 36.1% incidence 
of phlebitis among patients with PIVC. Global-
ly, the incidence rate was reported between 0.5 
% and 59.1%. Danski, Oliveira, Johann, Pedrolo, 
and Vayego (2015) and Enes et al. (2016) iden-
tified a 36.5% and 31.1% incidence rates of 
phlebitis in Spain and Brazil, respectively, which 
support the rate reported in the current study. 
However, both studies had a smaller sample si-
ze of 92 and 122, respectively, compared with 
this study. 
 
As previously explained, the difference in the 
incidence of phlebitis between studies may be 
related to differences in sample size. However, 
the reasons can also be the different printing to-
ols to identify the level of phlebitis and the sligh-
tly different definition and grade of phlebitis. In 
line with this study, phlebitis was defined as 
grade two and above based on the VIP scores by 
Arias-Fernández et al. (2017). In their study, 
they calculated 5.6% (n= 10) incidence of phle-
bitis, which is lower than this study. Another 
study by Kaur et al. (2011) found a higher inci-
dence of phlebitis (56%; n= 112/200) by apply-
ing a similar VIP score tool. Also, the Infusion 
Nursing Society proposes the use of phlebitis 
scale by including grade one as phlebitis, whe-
reas Enes et al. (2016) reported phlebitis as the 
most frequent complication (31.1%). Summari-
zing the results of some of these studies agrees 
with this research, including varying phlebitis 
levels from 5.6% to 56%. However, in this stu-
dy, the incidence of phlebitis was considered 
high compared with that in previous studies by 
Arias-Fernández et al. (2017), Danski et al. 
(2015), and Enes et al. (2016). 
 
A significant relationship was found between 
age groups and phlebitis incidence in this study. 
The age group of 40 years and above was a pre-
dictor factor for developing phlebitis. This find-
ing was compatible with the results of Wallis et 
al. (2014) in which they reported a p-value of 
0.05. Wallis et al. (2014) reported that the mean 
age of patients with the highest incidence rate 
of phlebitis in their study was 51.6 years, but it 
was 52.8 years in our study. In this study, the 
significant relationship between age and phle-
bitis incidence may be because most of the par-
ticipants were from the advanced age group, 
who have fragile skin and are more vulnerab-  
le to phlebitis compared with younger patients 
(Pagán, 2016). However, many previous studi-
es did not determine a significant relationship 
between age and phlebitis incidence, which co-
uld indicate that the high prevalence of phlebitis 
among the advanced age group could be redu-
ced and prevented. 
 
In this study, a significant relationship was fo-
und between gender and phlebitis development, 
which agrees with the studies of Abolfotouh, 
Salam, Bani Mustafa, White, and Balkhy (2014), 
Roca et al. (2012), and Wallis et al. (2014). In 
these previous studies, the portion of male par-
ticipants was more significant than female par-
ticipants, but in the current study, male patients 
had a higher incidence rate of phlebitis than 
female patients. It may be because there were 
more male patients in the orthopedic and me-
dical wards, which were categorized as busy 
and hectic wards, compared with female pati-
ents who were more often from the gynecology 
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wards (Wallis et al., 2014). However, some stu-
dies by Kaur et al. (2011) and Saini et al. (2011) 
determined that the percentage of phlebitis a-
mong male patients was higher than among fe-
male patients, which was similar to this study. 
Nevertheless, the p-value showed no significant 
relationship between gender and phlebitis inci-
dence in these studies (Kaur et al., 2011; Saini 
et al., 2011). 
 
This study revealed that patients with phlebitis 
history significantly contributed to phlebitis in-
cidence (45.3%). In comparison with other stu-
dies, Wallis et al. (2014) found no significant 
relationship between the history and incidence 
of phlebitis, with only 0.53% reported. In this 
study, the data were assessed by directly inter-
viewing patients, which may also have contri-
buted to bias due to overreporting or underre-
porting issues. However, it may be necessary 
to record patients’ history of phlebitis on a PIVC-
related form in the hospital to make nurses a-
ware that that these patients are prone to deve-
lop phlebitis quickly and to encourage nurses to 
take precautionary steps to minimize the risk of 
phlebitis. 
 
Patients with chronic disease conditions show-
ed a significant association with the incidence 
of phlebitis. This study finding corroborates a-
nother study by Enes et al. (2016), which de-
termined that patients with chronic diseases had 
a significantly higher risk of developing phle-
bitis. Nevertheless, few studies found a contra-
dictory result to the current study findings, in 
which the presence of chronic disease does not 
give significant results regarding the develop-
ment of phlebitis. However, Danski et al. (2015) 
suggested that patients without comorbidities or 
chronic diseases quickly recovered during hos-
pitalization, which resulted in a lower occurren-
ce of phlebitis. Therefore, it has been reported 
that patients with chronic disease conditions we-
re at higher risk of phlebitis compared with pa-






The high incidence rate of phlebitis acknow-
ledged in this study indicated a worrying result 
for our healthcare system. It can also be conclu-
ded that the most significant risk factors for phle-
bitis are men, aged 40 years and above, and chro-
nic disease history. These findings demonstrate 
that patients’ characteristics also contribute to 
the development of phlebitis, although cathe-
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